Tetraphase: La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
La Jolla agreement provides for $43.0 million in upfront cash plus potential future cash payments...
Read full article »
Tetraphase is a biopharmaceutical company that develops and commercializes novel tetracyclines for bacterial infections and orphan diseases.
Read more